Medline announced today the launch of its Vascular Access Health Solution, a new central line-associated bloodstream infection (CLABSI) prevention solution driven by human factors-based...
Lupin Pharmaceuticals Inc., (Lupin), and Exeltis USA Inc. announced a promotional agreement for Exeltis to promote SOLOSEC® along with Exeltis' existing line of Women's...
BioCentriq announces it has completed the construction of a state of the art GMP-ready clinical manufacturing facility in South Brunswick, New Jersey. The new...
South Carolina's Integrated Micro-Chromatography Systems, Inc. (IMCS), a leader in recombinant enzymes and micro-chromatography technologies, was awarded $1.8 million for Phase II of its...
